Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
KLOW is a research-context name for a four-peptide blend that combines GHK-Cu, KPV, BPC-157, and TB-500 in a single vial
Less common systemic effects that some users report include mild dizziness or lightheadedness, temporary nausea, mild headache, and occasional fatigue
Current Availability and Regulatory Status in the UK Retatrutide is not approved for clinical use in the UK and has no MHRA or EMA marketing authorisation
Supplied strictly for laboratory research use, with fast European delivery
US$ 22.32
US$ 21.32
US$ 20.69
